Strategies to increase primary care provider capacity for hepatitis C care: The California ECHO-PLUS study.
elimination
hub and spoke
screening
telementoring
treatment
Journal
Journal of viral hepatitis
ISSN: 1365-2893
Titre abrégé: J Viral Hepat
Pays: England
ID NLM: 9435672
Informations de publication
Date de publication:
05 2023
05 2023
Historique:
revised:
16
12
2022
received:
02
11
2022
accepted:
15
01
2023
medline:
20
4
2023
pubmed:
26
1
2023
entrez:
25
1
2023
Statut:
ppublish
Résumé
Expanding capacity to screen and treat those infected with the hepatitis C virus (HCV) is an essential element of the global elimination strategy. We evaluated the hub-and-spoke Project ECHO training versus telementoring models to educate, train and support HCV care by primary care providers in 13 targeted counties in northern California. A novel provider engagement strategy was used. Provider engagement and retention, time to readiness to treat HCV, and knowledge and confidence were the outcomes of interest. 94 participants from 60 unique clinics in the target counties participated in the ECHO-PLUS programme; 39.4% were physicians, 48.9% were advanced practice providers, and 11.7% were nurses. The median (range) participation time was 5 (1-49) hours. Confidence scores (minimum score = 13 and maximum score = 65) increased by a mean of 14.0 (SD:8.2) and 11.4 (SD:12.0) points for the hub-and-spoke and telementoring programmes, respectively (p = .53), with the largest changes in confidence seen in treating patients per guidelines, managing side effects and in serving as a consultant for HCV in their clinic. Among 24 participants with data on time to treatment, median time from beginner to experienced was 8 h (IQR:6-12) for hub-and-spoke and 2 h (IQR:1-2.4) for the telementoring programme (p = .01). A 'boots on the ground' approach to recruiting HCV champions was effective within rural communities. Both tele-ECHO hub-and-spoke and telementoring approaches to training primary care providers yielded increase in knowledge and confidence in HCV care and amplified the number of patients who were screened and treated. Telementoring accelerated the timeline of novice providers being 'ready to treat'.
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
397-405Informations de copyright
© 2023 The Authors. Journal of Viral Hepatitis published by John Wiley & Sons Ltd.
Références
Rosenberg ES, Rosenthal EM, Hall EW, et al. Prevalence of hepatitis C virus infection in US states and the District of Columbia, 2013 to 2016. JAMA Netw Open. 2018;1:e186371.
Arora S, Thornton K, Murata G, et al. Outcomes of treatment for hepatitis C virus infection by primary care providers. N Engl J Med. 2011;364:2199-2207.
Arora S, Kalishman S, Thornton K, et al. Expanding access to hepatitis C virus treatment-extension for community healthcare outcomes (ECHO) project: disruptive innovation in specialty care. Hepatology. 2010;52:1124-1133.
Piao C, Terrault NA, Sarkar S. Telemedicine: an evolving field in Hepatology. Hepatol Commun. 2019;3:716-721.
Rossaro L, Torruellas C, Dhaliwal S, et al. Clinical outcomes of hepatitis C treated with pegylated interferon and ribavirin via telemedicine consultation in northern California. Dig Dis Sci. 2013;58:3620-3625.
Rossaro L, Tran TP, Ransibrahmanakul K, et al. Hepatitis C videoconferencing: the impact on continuing medical education for rural healthcare providers. Telemed J E Health. 2007;13:269-277.
Polaris Observatory HCVC. Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study. Lancet Gastroenterol Hepatol. 2022;7:396-415.
Tran L, Feldman R, Riley T 3rd, Jung J. Association of the Extension for community healthcare outcomes project with use of direct-acting antiviral treatment among US adults with hepatitis C. JAMA Netw Open. 2021;4:e2115523.
Koepke R, Akhtar WZ, Kung VM, Seal DW, Salisbury-Afshar E, Westergaard RP. Hepatitis C treatment knowledge and practice among family medicine physicians in Wisconsin during the current hepatitis C epidemic. WMJ. 2021;120:106-113.
Stephens D, Leston J, Terrault NA, et al. An Evaluation of Hepatitis C Virus Telehealth Services Serving Tribal Communities: Patterns of Usage, Evolving Needs, and Barriers. J Public Health Manag Pract. 2019;25:S97-S100.
Tahan V, Almashhrawi A, Kahveci AM, Mutrux R, Ibdah JA. Extension for community health outcomes-hepatitis C: small steps carve big footprints in the allocation of scarce resources for hepatitis C virus treatment to remote developing areas. World J Hepatol. 2016;8:509-512.
Du P, Wang X, Kong L, Jung J. Can Telementoring reduce urban-rural disparities in utilization of direct-acting antiviral agents? Telemed J E Health. 2021;27:488-494.
Pindyck T, Kalishman S, Flatow-Trujillo L, Thornton K. Treating hepatitis C in American Indians/Alaskan natives: a survey of project ECHO((R)) (extension for community healthcare outcomes) utilization by Indian Health Service providers. SAGE Open Med. 2015;3:2050312115612805.
Agley J, Delong J, Janota A, Carson A, Roberts J, Maupome G. Reflections on project ECHO: qualitative findings from five different ECHO programs. Med Educ Online. 2021;26:1936435.
Mason JD, Dino G, Boyd J, et al. Amplifying expertise in rural West Virginia through project ECHO: impactful partnerships and community-engagement. Prog Community Health Partnersh. 2021;15:235-242.